News from trevena, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 15, 2013, 08:00 ET

First Clinical Experience of Trevena's lead CNS Biased Ligand, TRV130, Published in Journal of Clinical Pharmacology

 Trevena, Inc. (Trevena), a clinical stage pharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased...

Oct 10, 2013, 07:00 ET

Trevena Files Registration Statement for Proposed Initial Public Offering

 Trevena, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC)...

Sep 17, 2013, 13:18 ET

Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer

 Trevena, Inc., (Trevena) a clinical stage pharmaceutical company and a leader in the discovery and development of G-protein coupled receptor...

Jul 30, 2013, 07:00 ET

Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study

 Trevena, Inc., the leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, announced today the publication of new...

Jul 17, 2013, 07:00 ET

Trevena Granted Key Composition of Matter Patent for TRV027 in U.S.

Trevena, Inc., (Trevena) a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor...

Jul 08, 2013, 07:00 ET

Journal of Clinical Pharmacology Publishes First Clinical Experience with Trevena's Heart Failure Biased Ligand TRV027

 Trevena, Inc. (Trevena), a clinical stage pharmaceutical company and the leader in the discovery of G-protein coupled receptor (GPCR) biased...

May 09, 2013, 06:00 ET

Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure

Trevena, Inc., (Trevena) a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor...

Apr 22, 2013, 09:00 ET

Trevena, Inc. to Present at the 12th Annual Needham Healthcare Conference

 Trevena, Inc. a clinical stage pharmaceutical company today announced that its President and CEO, Dr. Maxine Gowen will present at the 12th...

Mar 05, 2008, 00:00 ET

Trevena, Inc. Announces $24 Million Series A Financing

BERWYN, Penn., March 5 /PRNewswire/ -- Trevena, Inc., a drug discovery company focused on developing pharmaceutical products targeting G-protein...